Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.69 USD | +9.82% | +9.82% | -3.91% |
05-14 | Transcript : Acumen Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-08 | Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.91% | 222M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+47.81% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.
- BTIG Adjusts Acumen Pharmaceuticals' Price Target to $22 From $15, Reiterates Buy Rating